Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Plasma homocysteine levels and risk of Alzheimer disease.
J A Luchsinger; M-X Tang; S Shea; J Miller; R Green; R Mayeux (Profiled Author: Mayeux, Richard)
Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, USA.
Neurology 2004;62(11):1972-6.
OBJECTIVE: To explore the association between high homocysteine levels and risk of Alzheimer disease (AD) in the Washington Heights-Inwood Columbia Aging Project (WHICAP). METHODS: The authors obtained fasting plasma samples in 909 elderly subjects chosen at random from a cohort of Medicare recipients; there was longitudinal data in 679 subjects without dementia at baseline who were followed for 3,206 person-years. Prevalent and incident dementia and its subtypes were diagnosed using standard methods. RESULTS: There were 128 persons with prevalent AD and 109 with incident AD in 3,206 person-years of follow-up. The adjusted OR of prevalent AD for the highest quartile of homocysteine compared to the lowest was 1.3 (95% CI = 0.7, 2.3; p for trend = 0.25). In longitudinal analyses, the authors found that the adjusted hazard ratio of AD for the highest quartile of homocysteine was 1.4 (95% CI = 0.8, 2.4; p for trend = 0.31). The authors also found that high homocysteine levels were not related to a decline in memory scores over time. Age was a significant confounder in all the analyses. The study had 80% power to detect a hazard ratio of 1.3 in the longitudinal analyses. CONCLUSION: High homocysteine levels were not associated with AD and were not related to a decrease in memory scores over time.
1 Originating Grant
-
1.
Mayeux, Richard
Epidemiology of Dementia In An Urban Community
1 February 1989 - 30 June 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 40,531,208
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
MAYEUX, RICHARD
Epidemiology of Biomarkers of Risk and Progression in LOAD
1 May 2010 - 30 April 2015
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,932,714
-
2.
Thal, Leon J
ALZHEIMER'S DISEASE COOPERATIVE STUDY
30 September 1991 - 31 August 2006
NATIONAL INSTITUTE ON AGING
Total Funding: $ 101,247,675
-
3.
MATTSON, MARK
Apoptosis In Neurodegenerative Disorders
NATIONAL INSTITUTE ON AGING
Total Funding: $ 2,357,366
Related Publications
-
1.
2001J Gottfries; K Blennow; M W Lehmann; B Regland; C G Gottfries
Journal of geriatric psychiatry and neurology 2001;14(3):109-14. -
2.
2003Paul S Aisen; Susan Egelko; Howard Andrews; Ramon Diaz-Arrastia; Myron Weiner; Charles DeCarli; William Jagust; Joshua W Miller; Ralph Green; Karen Bell; et al.
A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(2):246-9. -
3.
2005A L Boxer; J H Kramer; K Johnston; J Goldman; R Finley; B L Miller
Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
Neurology 2005;64(8):1431-4.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
385









-
1353









-
378









-
236









-
609









-
779










